Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Edmund Kostewicz"'
Autor:
Bertil Abrahamsson, James Butler, Rodrigo Cristofoletti, Christos Reppas, Edmund Kostewicz, Christoph Saal
Publikováno v:
Journal of Pharmaceutical Sciences. 111:14-17
Autor:
Erik Sjögren, James Butler, Vidula Kolhatkar, Xavier Pepin, Lynne S. Taylor, Andrew Babiskin, Sandra Suarez-Sharp, Paul Seo, Jennifer B. Dressman, Christer Tannergren, André Dallmann, Xinyuan Zhang, Poonam Delvadia, Edmund Kostewicz, Yang Zhao, Amitava Mitra, Filippos Kesisoglou, Mirko Koziolek, Neil Parrott
Publikováno v:
Journal of Pharmaceutical Sciences. 110:567-583
This workshop report summarizes the proceedings of Day 1 of a three-day workshop on “Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls”. Physiologica
Autor:
Jennifer B. Dressman, Karl J. Box, David B. Turner, Edmund Kostewicz, René Holm, Martin Kuentz, Chara Litou, Nico Holmstock, Jens Ceulemans
Publikováno v:
European Journal of Pharmaceutical Sciences
Introduction : In the development of bio-enabling formulations, innovative in vivo predictive tools to understand and predict the in vivo performance of such formulations are needed. Etravirine, a non-nucleoside reverse transcriptase inhibitor, is cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1dd04f1a01df8b73f4a01e8f7595685
http://publikationen.ub.uni-frankfurt.de/files/53224/Etravirine_research_paper_local_repository.pdf
http://publikationen.ub.uni-frankfurt.de/files/53224/Etravirine_research_paper_local_repository.pdf
Publikováno v:
AAPS PharmSciTech. 19:2885-2897
Food effects on oral drug bioavailability are a consequence of the complex interplay between drug, formulation and human gastrointestinal (GI) physiology. Accordingly, the prediction of the direction and the extent of food effects is often difficult.
Autor:
Shriram M. Pathak, Nikunjkumar Patel, Aaron Ruff, Edmund Kostewicz, Masoud Jamei, David B. Turner
Publikováno v:
Molecular Pharmaceutics. 14:4305-4320
Mechanistic modeling of in vitro data generated from metabolic enzyme systems (viz., liver microsomes, hepatocytes, rCYP enzymes, etc.) facilitates in vitro–in vivo extrapolation (IVIV_E) of metabolic clearance which plays a key role in the success
Autor:
Richard Lloyd, Leon Aarons, Mark McAllister, Amitava Mitra, Chester Costales, Timo Korjamo, Maria Hammarberg, Helena Thörn, Carole Shardlow, Jussi Malkki, Adam S. Darwich, Tycho Heimbach, Achiel Van Peer, James M. Mullin, Jennifer B. Dressman, Johanna Laru, Dónal Murphy, Handan He, Jian Lin, Irina Mishenzon, Ke X. Szeto, Mei Wong, Peter Langguth, Bertil Abrahamsson, Carolin Hoft, Fan Wu, Mohammed Yasin, Olivier Nicolas, Manthena V.S. Varma, Alison Margolskee, Christer Tannergren, Edmund Kostewicz, Yan Pang, Shriram M. Pathak, Johanna Tuunainen, Constanze Hilgendorf, Sari Pappinen, Viera Lukacova, Charles J. Rotter, Jan Bevernage, Sweta Modi, Sergej Ramusovic, Simone Hansmann, Mai Anh Nguyen, Amin Rostami-Hodjegan, Eva Huehn, Michael B. Bolger, Jonathan Brown, Loic Laplanche, Christine Xu, Eva Karlsson, Sara Carlert, Pernilla Johansson, Florent Mazuir, Jeike Biewenga, Xavier Pepin, Hans Lennernäs, Aleksandra Galetin
Publikováno v:
Margolskee, A, Darwich, A, Aarons, L, Galetin, A, Rostami-Hochaghan, A, Carlert, S, Hammarberg, M, Hilgendorf, C, Johansson, P, Karlsson, E, Murphy, D, Tannergren, C, Thorn, H, Yasin, M, Mazuir, F, Nicolas, O, Ramusovic, S, Xu, C, Pathak, S, Korjamo, T, Laru, J, Malkki, J, Pappinen, S, Tuunainen, J, Dressman, J, Hansmann, S, Kostewicz, E, He, H, Heimbach, T, Wu, F, Hoft, C, Laplanche, L, Pang, Y, Bolger, M B, Huehn, E, Lukacova, V, Mullin, J M, Szeto, K X, Costales, C, Lin, J, McAllister, M, Modi, S, Rotter, C, Varma, M, Wong, M, Mitra, A, Bevernage, J, Biewenga, J, Van Peer, A, Lloyd, R, Shardlow, C, Langguth, P, Mishenzon, I, Nguyen, M A, Brown, J, Lennernas, H & Abrahamsson, B 2016, ' IMI – Oral Biopharmaceutics Tools project – Evaluation of Bottom-up PBPK Prediction Success Part 2: An Introduction to the Simulation Exercise and Overview of Results ', European Journal of Pharmaceutical Sciences . https://doi.org/10.1016/j.ejps.2016.10.036
Orally administered drugs are subject to a number of barriers impacting bioavailability (Foral), causing challenges during drug and formulation development. Physiologically-based pharmacokinetic (PBPK) modelling can help during drug and formulation d
Autor:
Edmund Kostewicz, Steve Young, Karin Bracht, David P. Elder, Axel Zeitler, Mark Santillo, James Mann, Karl J. Box, James Butler
Publikováno v:
Dissolution Technologies. 24:62-67
Autor:
Cord J. Andreas, Christos Reppas, Patrick Augustijns, Filippos Kesisoglou, Mans Minekus, Kerstin Julia Schaefer, James Butler, Mirko Koziolek, Philipp Jedamzik, Bart Hens, Edmund Kostewicz, Masoud Jamei, James Mann, Joachim Brouwers, Jennifer B. Dressman, Philippe Berben, Maria Vertzoni, Ronald Schilderink, Peter Langguth, Werner Weitschies, Anette Müllertz, Mark McAllister
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics, 136, 70-83
Butler, J, Hens, B, Vertzoni, M, Brouwers, J, Berben, P, Dressman, J, Andreas, C J, Schaefer, K J, Mann, J, McAllister, M, Jamei, M, Kostewicz, E, Kesisoglou, F, Langguth, P, Minekus, M, Mullertz, A, Schilderink, R, Koziolek, M, Jedamzik, P, Weitschies, W, Reppas, C & Augustijns, P 2019, ' In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration ', European Journal of Pharmaceutics and Biopharmaceutics, vol. 136, pp. 70-83 . https://doi.org/10.1016/j.ejpb.2018.12.010
Butler, J, Hens, B, Vertzoni, M, Brouwers, J, Berben, P, Dressman, J, Andreas, C J, Schaefer, K J, Mann, J, McAllister, M, Jamei, M, Kostewicz, E, Kesisoglou, F, Langguth, P, Minekus, M, Mullertz, A, Schilderink, R, Koziolek, M, Jedamzik, P, Weitschies, W, Reppas, C & Augustijns, P 2019, ' In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration ', European Journal of Pharmaceutics and Biopharmaceutics, vol. 136, pp. 70-83 . https://doi.org/10.1016/j.ejpb.2018.12.010
The availability of in vitro tools that are constructed on the basis of a detailed knowledge of key aspects of gastrointestinal (GI) physiology and their impact on formulation performance and subsequent drug release behaviour is fundamental to the su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f10d1098653469cf4ea88dbed0ea6a9
http://resolver.tudelft.nl/uuid:6d550c74-1751-4915-ba01-df580dc8a211
http://resolver.tudelft.nl/uuid:6d550c74-1751-4915-ba01-df580dc8a211
Publikováno v:
European Journal of Pharmaceutical Sciences. 155:105552
The aim of this study was to use a combined in vitro-in silico approach to develop a physiologically based pharmacokinetic model (PBPK) that predicts the bioavailability of albendazole (ABZ), a BCS class II/IV lipophilic weak base, and simulates its
Autor:
Chara Litou, Christos Reppas, Karl J. Box, Jennifer B. Dressman, Patrick J O'Dwyer, Martin Kuentz, Edmund Kostewicz
Publikováno v:
Journal of Pharmacy and Pharmacology
Objectives Drug precipitation in vivo poses a significant challenge for the pharmaceutical industry. During the drug development process, the impact of drug supersaturation or precipitation on the in vivo behaviour of drug products is evaluated with